Regenxbio Cost Of Revenue from 2010 to 2025

RGNX Stock  USD 6.60  0.07  1.05%   
Regenxbio Cost Of Revenue yearly trend continues to be fairly stable with very little volatility. Cost Of Revenue is likely to outpace its year average in 2025. During the period from 2010 to 2025, Regenxbio Cost Of Revenue regression line of annual values had r-squared of  0.75 and arithmetic mean of  18,211,853. View All Fundamentals
 
Cost Of Revenue  
First Reported
2013-12-31
Previous Quarter
14.6 M
Current Value
12.4 M
Quarterly Volatility
6.3 M
 
Yuan Drop
 
Covid
Check Regenxbio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Regenxbio's main balance sheet or income statement drivers, such as Depreciation And Amortization of 20.9 M, Interest Expense of 7.5 M or Selling General Administrative of 106.9 M, as well as many indicators such as Price To Sales Ratio of 9.5, Dividend Yield of 0.0 or PTB Ratio of 2.38. Regenxbio financial statements analysis is a perfect complement when working with Regenxbio Valuation or Volatility modules.
  
Check out the analysis of Regenxbio Correlation against competitors.
For more information on how to buy Regenxbio Stock please use our How to Invest in Regenxbio guide.

Latest Regenxbio's Cost Of Revenue Growth Pattern

Below is the plot of the Cost Of Revenue of Regenxbio over the last few years. Cost of Revenue is found on Regenxbio income statement and represents the costs associated with goods and services Regenxbio provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities. It is Regenxbio's Cost Of Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Regenxbio's overall financial position and show how it may be relating to other accounts over time.
Cost Of Revenue10 Years Trend
Slightly volatile
   Cost Of Revenue   
8.2M35.751.854.537.242.844.9333%45%5%-32%15%5%100%
       Timeline  

Regenxbio Cost Of Revenue Regression Statistics

Arithmetic Mean18,211,853
Geometric Mean4,337,390
Coefficient Of Variation118.91
Mean Deviation19,720,441
Median8,241,000
Standard Deviation21,655,300
Sample Variance469T
Range54.2M
R-Value0.86
Mean Square Error127.6T
R-Squared0.75
Significance0.000016
Slope3,928,919
Total Sum of Squares7034.3T

Regenxbio Cost Of Revenue History

202544.9 M
202442.8 M
202337.2 M
202254.5 M
202151.8 M
202035.7 M
20198.2 M

About Regenxbio Financial Statements

Regenxbio investors use historical fundamental indicators, such as Regenxbio's Cost Of Revenue, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Regenxbio. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Cost Of Revenue42.8 M44.9 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Regenxbio Stock Analysis

When running Regenxbio's price analysis, check to measure Regenxbio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Regenxbio is operating at the current time. Most of Regenxbio's value examination focuses on studying past and present price action to predict the probability of Regenxbio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Regenxbio's price. Additionally, you may evaluate how the addition of Regenxbio to your portfolios can decrease your overall portfolio volatility.
News Freq…Investor S…